SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?


To: Stanley Cowen who wrote (668)6/5/1998 1:39:00 PM
From: Harold Engstrom  Read Replies (1) | Respond to of 1686
 
Does anyone think the low volume this week is very abnormal? It is past 1pm and once again just over 100K shares have traded. Does anyone have any explanation for such light volume lately?

I agree that the CVT-124 press release does seem positive. I know Biogen is reluctant to put a positive spin on data since being sued over the Hirulog comments Jim Vincent made in 1994. The larger phaseIIb study should be in full swing this summer with results in the fall.



To: Stanley Cowen who wrote (668)6/19/1998 3:34:00 PM
From: Harold Engstrom  Respond to of 1686
 
Forgot an interesting 5C8 note: New England Journal of Medicine article this week about transplantation biology. The article reputedly keys on the CD40L pathway.